Varaico: Literature-Extracted Genetic Variants

Gene:LMNA
Variant:p.Y259*
Back to variants list

LMNA

NM_170707.4:p.Y259*

Associated Papers

Selection of specific and efficient siRNAs in new cellular model for Hutchinson-Gilford progeria syndrome therapy.

Dzianisava V et al.

Molecular Therapy. Nucleic Acids, 2025

41147012 (PubMed )
Supplement: mmc4.pdf

Genetic and Pathophysiological Basis of Cardiac and Skeletal Muscle Laminopathies.

Bhide S et al.

Genes, 2024

Somatic and germinal mosaicism in a Han Chinese family with laminopathies.

Wang G et al.

European Journal of Human Genetics : Ejhg, 2023

Nuclear proteostasis imbalance in laminopathy-associated premature aging diseases.

Pande S et al.

Faseb Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2023

Epigenetics in LMNA-Related Cardiomyopathy.

Wang Y et al.

Cells, 2023

Overview of cellular homeostasis-associated nuclear envelope lamins and associated input signals.

Kim HJ et al.

Frontiers in Cell and Developmental Biology, 2023

Genotype-Phenotype Correlations in Human Diseases Caused by Mutations of LINC Complex-Associated Genes: A Systematic Review and Meta-Summary.

Storey EC et al.

Cells, 2022

36552829 (PubMed )
Supplement: cells-11-04065-s001.zip › Storey___Fuller_Supplementary_Materials_S2_Data_extraction.xlsx › Lamins

Consequences of Lmna Exon 4 Mutations in Myoblast Function.

Gómez-Domínguez D et al.

Cells, 2020

An Emerin LEM-Domain Mutation Impairs Cell Response to Mechanical Stress.

Essawy N et al.

Cells, 2019

Large next-generation sequencing gene panels in genetic heart disease: yield of pathogenic variants and variants of unknown significance.

van Lint FHM et al.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 2019

30847666 (PubMed )
Supplement: 12471_2019_1250_MOESM2_ESM.xlsx › Blad1

Assessment of fibroblast nuclear morphology aids interpretation of LMNA variants.

van Tienen FHJ et al.

European Journal of Human Genetics : Ejhg, 2019

Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson-Gilford progeria syndrome fibroblasts.

Bikkul MU et al.

Biogerontology, 2018

Lamin missense mutations-the spectrum of phenotype variability is increasing.

Captur G et al.

European Journal of Heart Failure, 2018

Mechanisms of allelic and clinical heterogeneity of lamin A/C phenotypes.

Perovanovic J et al.

Physiological Genomics, 2018

Laminopathies; Mutations on single gene and various human genetic diseases.

Kang SM et al.

Bmb Reports, 2018

Clinical aspects of Emery-Dreifuss muscular dystrophy.

Madej-Pilarczyk A

Nucleus (austin, Tex.), 2018

Lamin A/C-Related Cardiac Disease: Late Onset With a Variable and Mild Phenotype in a Large Cohort of Patients With the Lamin A/C p.(Arg331Gln) Founder Mutation.

Hoorntje ET et al.

Circulation. Cardiovascular Genetics, 2017

28790152 (PubMed )
Supplement: circgenetics_circcvg-2016-001631_supp1.pdf

Skeletal Muscle Laminopathies: A Review of Clinical and Molecular Features.

Maggi L et al.

Cells, 2016

Tying up loose ends: telomeres, genomic instability and lamins.

Gonzalo S et al.

Current Opinion in Genetics & Development, 2016

Altering lamina assembly reveals lamina-dependent and -independent functions for A-type lamins.

Zwerger M et al.

Journal of Cell Science, 2015

Lamin A/C-dependent interaction with 53BP1 promotes cellular responses to DNA damage.

Gibbs-Seymour I et al.

Aging Cell, 2015

Sustained accumulation of prelamin A and depletion of lamin A/C both cause oxidative stress and mitochondrial dysfunction but induce different cell fates.

Sieprath T et al.

Nucleus (austin, Tex.), 2015

First report of a novel LMNA mutation in a Chinese family with limb-girdle muscular dystrophy.

Hong G et al.

Journal of Genetics, 2014

The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.

Al-Saaidi R et al.

Experimental Cell Research, 2013

Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations.

Carboni N et al.

Muscle & Nerve, 2013

Defective skeletal muscle growth in lamin A/C-deficient mice is rescued by loss of Lap2α.

Cohen TV et al.

Human Molecular Genetics, 2013

Cytoplasmic localization of PML particles in laminopathies.

Houben F et al.

Histochemistry and Cell Biology, 2013

Lamin A/C haploinsufficiency modulates the differentiation potential of mouse embryonic stem cells.

Sehgal P et al.

Plos One, 2013

Ubiquitin ligase RNF123 mediates degradation of heterochromatin protein 1α and β in lamin A/C knock-down cells.

Chaturvedi P et al.

Plos One, 2012

Conserved cysteine residues in the mammalian lamin A tail are essential for cellular responses to ROS generation.

Pekovic V et al.

Aging Cell, 2011

Repetitive disruptions of the nuclear envelope invoke temporary loss of cellular compartmentalization in laminopathies.

De Vos WH et al.

Human Molecular Genetics, 2011

LMNA cardiomyopathy: cell biology and genetics meet clinical medicine.

Lu JT et al.

Disease Models & Mechanisms, 2011

Lamins, laminopathies and disease mechanisms: possible role for proteasomal degradation of key regulatory proteins.

Parnaik VK et al.

Journal of Biosciences, 2011

[Laminopathies: one gene, several diseases].

Bertrand AT et al.

Biologie Aujourd'hui, 2011

Lamin A rod domain mutants target heterochromatin protein 1alpha and beta for proteasomal degradation by activation of F-box protein, FBXW10.

Chaturvedi P et al.

Plos One, 2010

Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.

Gupta P et al.

Basic Research in Cardiology, 2010

Increased plasticity of the nuclear envelope and hypermobility of telomeres due to the loss of A-type lamins.

De Vos WH et al.

Biochimica Et Biophysica Acta, 2010

Genotype-phenotype correlations in laminopathies: how does fate translate?

Scharner J et al.

Biochemical Society Transactions, 2010

Defects in cell spreading and ERK1/2 activation in fibroblasts with lamin A/C mutations.

Emerson LJ et al.

Biochimica Et Biophysica Acta, 2009

Disturbed nuclear orientation and cellular migration in A-type lamin deficient cells.

Houben F et al.

Biochimica Et Biophysica Acta, 2009

Incomplete nonsense-mediated decay of mutant lamin A/C mRNA provokes dilated cardiomyopathy and ventricular tachycardia.

Geiger SK et al.

Journal of Molecular Medicine (berlin, Germany), 2008

Nesprin-2 giant safeguards nuclear envelope architecture in LMNA S143F progeria cells.

Kandert S et al.

Human Molecular Genetics, 2007

High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.

van Tintelen JP et al.

American Heart Journal, 2007

Nuclear envelope defects in muscular dystrophy.

Roux KJ et al.

Biochimica Et Biophysica Acta, 2007

Proteasome-mediated degradation of integral inner nuclear membrane protein emerin in fibroblasts lacking A-type lamins.

Muchir A et al.

Biochemical and Biophysical Research Communications, 2006

Workshop on the nuclear envelope and Emery-Dreifuss muscular dystrophy 29th March 2006, Oswestry, UK.

Natalie Randles K et al.

Neuromuscular Disorders : Nmd, 2006

The laminopathies: a clinical review.

Rankin J et al.

Clinical Genetics, 2006

Laminopathies: multiple disorders arising from defects in nuclear architecture.

Parnaik VK et al.

Journal of Biosciences, 2006

1–50 of 63 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."